Published in J Dtsch Dermatol Ges on October 01, 2011
Female pattern alopecia: current perspectives. Int J Womens Health (2013) 0.95
Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. Int J Trichology (2014) 0.94
Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg (2015) 0.86
Female pattern hair loss. Int J Endocrinol Metab (2013) 0.84
Dermatosis associated with menopause. J Midlife Health (2014) 0.81
The Diagnosis and Treatment of Hair and Scalp Diseases. Dtsch Arztebl Int (2016) 0.81
Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. Int J Trichology (2016) 0.77
Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management. Dermatol Ther (Heidelb) (2016) 0.75
HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS. AACE Clin Case Rep (2016) 0.75
Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: A Randomized Controlled Trial. J Res Pharm Pract (2017) 0.75
Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study. BMJ Open (2017) 0.75
Conventional and novel stem cell based therapies for androgenic alopecia. Stem Cells Cloning (2017) 0.75
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75
Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol (2006) 2.38
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med (2003) 2.12
Confusion about diffusion and the art of misinterpreting data when comparing different botulinum toxins used in aesthetic applications. J Cosmet Laser Ther (2008) 1.90
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis. Arch Dermatol (2010) 1.77
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg (2009) 1.72
Dermatologists' accuracy in early diagnosis of melanoma of the nail matrix. Arch Dermatol (2010) 1.64
Hair and scalp dermatoscopy. J Am Acad Dermatol (2012) 1.64
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents. J Am Acad Dermatol (2010) 1.59
Nanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in mice. J Invest Dermatol (2008) 1.59
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol (2007) 1.59
Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm (2006) 1.56
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood (2005) 1.54
Onychomatricoma: first description in a child. Pediatr Dermatol (2007) 1.50
A new dermoscopic finding in healthy children. Arch Dermatol (2009) 1.45
The epidemiology of skin care provided by nurses at home: a multicentre prevalence study. J Adv Nurs (2014) 1.40
Onychomycosis: diagnosis and definition of cure. J Am Acad Dermatol (2007) 1.37
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. Dermatol Surg (2010) 1.33
Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet (2009) 1.31
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol (2006) 1.31
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update. J Dtsch Dermatol Ges (2012) 1.25
Dermatoscopy of hair shaft disorders. J Am Acad Dermatol (2012) 1.21
Variations of hair follicle size and distribution in different body sites. J Invest Dermatol (2004) 1.15
Trachyonychia: a comprehensive review. Indian J Dermatol Venereol Leprol (2011) 1.14
Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano (2012) 1.13
Finasteride treatment of female pattern hair loss. Arch Dermatol (2006) 1.12
Nail clipping diagnosis of onychomatricoma. Arch Dermatol (2011) 1.11
One-year study on the variation of carotenoid antioxidant substances in living human skin: influence of dietary supplementation and stress factors. J Biomed Opt (2008) 1.08
Videodermoscopy of the hyponychium in nail bed psoriasis. J Am Acad Dermatol (2008) 1.07
The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol (2009) 1.07
Videodermoscopy: a useful tool for diagnosing congenital triangular alopecia. Pediatr Dermatol (2008) 1.07
Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol (2011) 1.06
Onchomycosis: an overview. J Drugs Dermatol (2013) 1.06
Docetaxel and permanent alopecia. J Am Acad Dermatol (2013) 1.06
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. Blood Cells Mol Dis (2007) 1.06
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol (2006) 1.06
Alopecic and aseptic nodules of the scalp. Dermatology (2008) 1.05
Alopecic and aseptic nodules of the scalp (pseudocyst of the scalp): a prospective clinicopathological study of 15 cases. Dermatology (2010) 1.05
Role of trichoscopy in children's scalp and hair disorders. Pediatr Dermatol (2013) 1.05
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer (2015) 1.04
Half and half nails: a past and present snapshot. Cutis (2011) 1.04
Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res (2009) 1.04
Effect of standardized skin care regimens on neonatal skin barrier function in different body areas. Pediatr Dermatol (2010) 1.03
Alopecia areata during treatment with biologic agents. Arch Dermatol (2006) 1.03
Heterochromia of the scalp hair following Blaschko lines. Pediatr Dermatol (2007) 1.02
Short anagen syndrome in an African American woman. J Am Acad Dermatol (2010) 1.02
Nail cosmetics in nail disorders. J Cosmet Dermatol (2007) 1.01
Drug-induced nail diseases. Dermatol Clin (2006) 1.01
A validated lip fullness grading scale. Dermatol Surg (2008) 1.01
Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol (2003) 1.00
The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the Injectable Filler Safety Study. Dermatol Surg (2009) 1.00
Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol (2008) 1.00
Histological features of peripilar signs associated with androgenetic alopecia. Arch Dermatol Res (2004) 1.00
Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Dermatol (2011) 0.99
Disclosure of potential conflicts of interest in dermatological guidelines in Germany - an analysis - status quo and quo vadis. J Dtsch Dermatol Ges (2011) 0.99
Contact allergens and irritants in household washing and cleaning products. Contact Dermatitis (2009) 0.99
A validated grading scale for forehead lines. Dermatol Surg (2008) 0.99
Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg (2007) 0.98
Follicular transport route--research progress and future perspectives. Eur J Pharm Biopharm (2008) 0.98
Monilethrix. J Pediatr (2012) 0.97
Interventions for nail psoriasis. Cochrane Database Syst Rev (2013) 0.97
Validated assessment scales for the lower face. Dermatol Surg (2012) 0.97
White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch Dermatol (2004) 0.97
[S3-guidelines for the treatment of psoriasis vulgaris Update 2011]. J Dtsch Dermatol Ges (2011) 0.96
Trichoscopy as a clue to the diagnosis of scalp sarcoidosis. Int J Dermatol (2011) 0.96
Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative dermatoscopy. J Am Acad Dermatol (2011) 0.96
A validated hand grading scale. Dermatol Surg (2008) 0.96
The disappearing nail bed: a possible outcome of onycholysis. Cutis (2005) 0.96
A validated grading scale for marionette lines. Dermatol Surg (2008) 0.95
Validated assessment scales for the upper face. Dermatol Surg (2012) 0.95
Profiling of alopecia areata autoantigens based on protein microarray technology. Mol Cell Proteomics (2005) 0.95
Loose anagen hair syndrome and loose anagen hair. Arch Dermatol (2002) 0.95
[Dermoscopy in nail psoriasis]. An Bras Dermatol (2010) 0.95
Onychopapilloma presenting as longitudinal melanonychia. J Am Acad Dermatol (2012) 0.95
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016. Eur J Cancer (2016) 0.95
Histopathologic features of alopecia areata incognito: a review of 46 cases. J Cutan Pathol (2012) 0.94
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation. Blood Cells Mol Dis (2004) 0.94
Successful treatment of calciphylaxis with pamidronate. Eur J Dermatol (2008) 0.94
N-acetylcysteine in the Treatment of Trichotillomania. Int J Trichology (2012) 0.94
A validated grading scale for crow's feet. Dermatol Surg (2008) 0.94
Anatomic guidelines for augmentation of the cheek and infraorbital hollow. Dermatol Surg (2012) 0.94
A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index. Arch Dermatol (2011) 0.94
Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol (2011) 0.94
Off-label use of azathioprine in dermatology: a systematic review. Arch Dermatol (2011) 0.94
Treatment of onychomycosis with oral antifungal agents. Expert Opin Drug Deliv (2005) 0.93
Diagnosis of hair disorders. Semin Cutan Med Surg (2009) 0.93
Permanent chemotherapy-induced alopecia: a review. J Am Acad Dermatol (2011) 0.92
The psychosocial impact of hair loss among men: a multinational European study. Curr Med Res Opin (2005) 0.92
Facial Soft-Tissue Fillers conference: Assessing the State of the Science. J Am Acad Dermatol (2011) 0.92
Differential stripping demonstrates a significant reduction of the hair follicle reservoir in vitro compared to in vivo. Eur J Pharm Biopharm (2008) 0.92
Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol (2015) 0.92
Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet (2011) 0.92
Grading simple chronic paronychia and onycholysis. Int J Dermatol (2006) 0.91
Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of alpha-melanocyte-stimulating hormone in human dermal papilla cells. Endocrinology (2005) 0.91
Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial. PLoS One (2010) 0.91
Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol (2012) 0.91
Short anagen syndrome. Pediatr Dermatol (2011) 0.91
Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl (2006) 0.91